NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,136 filers reported holding NOVARTIS A G in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,383,450 | +12.4% | 12,995 | +2.2% | 0.08% | +8.6% |
| Q1 2024 | $1,230,505 | -5.5% | 12,721 | -1.4% | 0.07% | -13.6% |
| Q4 2023 | $1,302,591 | -3.6% | 12,901 | -2.8% | 0.08% | -8.0% |
| Q3 2023 | $1,351,845 | +451.8% | 13,272 | +420.5% | 0.09% | -60.2% |
| Q1 2019 | $245,000 | – | 2,550 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 318,637 | $27,960,000 | 7.08% |
| MANAGED ASSET PORTFOLIOS, LLC | 417,183 | $36,608,000 | 5.02% |
| SAL Trading, LLC | 233,600 | $20,498,000 | 4.77% |
| SCHARF INVESTMENTS, LLC | 1,340,680 | $117,662,000 | 3.49% |
| SAL Trading, LLC | 155,783 | $13,670,000 | 3.18% |
| First Fiduciary Investment Counsel, Inc. | 169,371 | $14,862,000 | 2.90% |
| PRENTISS SMITH & CO INC | 55,026 | $4,829,000 | 2.90% |
| GARLAND CAPITAL MANAGEMENT INC | 47,630 | $4,180,000 | 2.77% |
| Cullen Capital Management, LLC | 3,295,271 | $289,160,000 | 2.66% |
| WILKINS INVESTMENT COUNSEL INC | 133,880 | $11,748,000 | 2.65% |